Pharmaceutical Company For Sale
Location Russia
Asking Price Range $5.0M - $10.0M
Gross Revenues $1600000
Net Profit / Cash Flow $1000000
Cash Flow Type Sellers Discretionary Cash
Seller Finance Not Disclosed
Year Established 2006
Number of Employees 10 - 19
Inventory 600000
Relocatable No
Number of Employees 10 - 19
Real Estate Leased
Training Management could stay in company.
Reason for Sale Non-core business.
Description Forte Pharmaceutical is a company, located in the Moscow, offers Drug and Nutraceutical applications, equipment, formulas, customers and non-sterile solid dosage-form manufacturing. Has Russian Federal State Approval to manufacture Ethic Drugs and Nutraceuticals applications. Company has long term Developed/Supply Agreement with Danish-based company, that developed and supply it with Probiotics Strains. Company has long term Sales Agreement with all major Wholesalers and Pharmacy Chains on territory of Russian Federation. Forte Pharmaceutical is expansion of Probiotic, its high margin, high value-added line of Nutraceutical applications.
Forte Pharmaceutical's new line of customized Probiotic, is poised to take advantage of a rapidly expanding market and higher margins. The outlook of consumption probiotic's is strong, according to Forte Pharmaceutical's own market intelligence and a third-party market analysis by RMBC.
In 2008, Forte Pharmaceutical Probiotic forecast sales of approximately 3.9 million units, producing $3.2 million in revenues. By 2012, it conservatively expects sales to grow to at least 10.5 million power units per annum, or $37.0 million in revenues. Revenues could exceed this level if the company can leverage its position in this segment of the market to the broader market (Ukraine, Kazakhstan).
The overall Pharmaceutical market is experiencing very robust growth with a good outlook for the future. According to research by RMBC, an industry analyst, Russian pharmaceutical market has been growing at 17.2% per annum over the last five years and, over the last year, the market has been growing at 27%.
Managing team has extensive experience in pharmaceutical manufacturing, sales and marketing, having worked in some capacity with many of the major Pharmaceutical Companies (Roche, Glaxo, Lek, Sandoz, Novartis) , in every major therapeutic category, and in a wide variety of product situations (Rx, OTC, launches of new, mature products.
Click Here To Contact Seller
For more opportunities like this go to:
|
|
NEWSLETTER
|
|
Sign up for Free Industry-Related News on Business and Franchise Opportunities
|
|